Skip to content
‹ Back to IndustriesSciences

Overcoming Problems with Hybrid Rocket Engines is Key to Launching Us Further into Space

Hybrid rocket engines combine elements of both liquid and solid propulsion systems to offer improved efficiency, safety, and control compared to traditional rocket technologies. Advances in hybrid propulsion are seen as a key enabler for more accessible and cost-effective space exploration. Greater accessibility to space could accelerate scientific discovery and technological innovation.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · HybridRobert FabianRocket EnginesSpace
Share

Key takeaways

01

Hybrid rocket engines offer a middle ground between liquid and solid propulsion, providing better control and safety.

02

Improved rocket technology lowers barriers to space exploration for commercial and scientific missions.

03

Ongoing development of hybrid engines could unlock new opportunities for deep space travel and research.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Hybrid isn’t just the word with us earthlings, it’s also the next big thing in space technology. Hybrid rocket engines have been developed to increase efficiency and control over more established liquid and solid rocket engines. With better rocket technology comes more accessible space exploration, meaning the potential for scientific discoveries and technological advancements grows exponentially. In fact, according to a report by Morgan Stanley, the global space industry could be worth $1.1 trillion or more by 2040.

Still, while hybrid rockets offer certain advantages over the more traditional rockets, they also come with several drawbacks, including the fact that refueling hybrid rockets is more challenging than refueling liquid and solid rockets. Large hybrid orbital rockets also require turbopumps, but turbopumps can’t use the same fuel and oxidizer as in liquid-propellant rockets. Finally, there hasn’t been as much research on hybrid rockets as with other rockets, so many of their problems have not been fully addressed.

Private aerospace company Vaya Space has been making waves in the industry with its revolutionary Vortex hybrid engine technology. Robert Fabian, the company’s Chief Operating Officer, offers deeper insights into this new technology and its potential impact on space travel.

Robert’s Thoughts:

“What makes Vaya Space unique really is our engine technology, what we call the Vortex hybrid engine. We’ve taken the historical problems of hybrid engines and core performance and combustion instability and solved them, producing an engine that’s significantly cheaper, significantly simpler, and significantly safer than anything else out there on the market.

When I first heard about this technology, I didn’t believe it. I had to do the math myself to make sure it would work, and I’ve watched it go from math on a page and a concept to lab scale tests, to larger engine tests, to flight tests, and I’m really looking forward to seeing the production engine for our Dauntless launch vehicle fire for the first time.”

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

SR-Tiget gene therapy families average six months in Milan and years of lab tests

SR-Tiget gene therapy families average six months in Milan and years of lab tests

Gene therapy at Milan’s SR-Tiget includes a family support programme that helps relatives manage months-long stays (often around six months) for treatment, while a regulated lab can track patient samples for up to 20 years. Follow-up visits can outnumber new treatments, adding to the long-term workload.

  • 01In 2025, SR-Tiget's family programme coordinated 133 follow-up visits against 17 new treatments. That gap keeps widening because each patient enters roughly 15 years of twice-yearly checkups.
  • 02At SR-Tiget, the average family spends six months in Milan, and the child's samples can keep reaching the lab for as long as twenty years.
  • 03Any gene therapy service has to answer one question: who tells the lab when a child's fever pushes a blood draw from morning to afternoon? In Milan, research nurses own that handoff.

Nov 16, 2026

Two photonic AI components reach outside testers—on limits

Two photonic AI components reach outside testers—on limits

Kopin is expanding microLED manufacturing in Westborough, Massachusetts, which could add up to 80 jobs over five years. Its microLEDs will go to military displays and to Neural I/o, an interconnect that sends AI data as light. In the same news round-up, Q.ANT and IONOS opened a photonic processor pilot where approved applicants can run their own workloads.

  • 01Two photonic approaches tied to AI’s power problem reached testable hardware this month: PsiQuantum’s 8×8 optical switch samples and Q.ANT’s second-generation processor via an IONOS bare-metal pilot in Germany.
  • 02PsiQuantum is sending samples of an 8×8 demonstration optical circuit switch to selected prospective customers, giving buyers hardware they can test even though commercial products and full specs are still pending.
  • 03Staffing may not keep up with demand: a 2023 Applied Optics study projected US demand for 42,000 new middle-skilled photonics workers by 2030, and expansions like Kopin's could draw from that same pool.

Nov 15, 2026

Lilly breaks ground on a $5B Virginia bioconjugate plant; first building expected in 2030

Lilly breaks ground on a $5B Virginia bioconjugate plant; first building expected in 2030

Lilly’s Goochland County site is designed to make APIs and finished medicines on one campus. Virginia Business reported the first building is expected to open in 2030.

  • 01Goochland’s pilot-scale training center is slated to open in 2028, two years before Lilly expects its first production building in 2030—signaling workforce readiness as the earliest milestone at Lilly’s first dedicated, fully integrated API and drug product facility for its bioconjugate platform and monoclonal antibody portfolio.
  • 02For anyone tracking new ADC supply, Goochland is a later story: Lilly expects to open the first building in 2030 and the second in 2031.

Nov 15, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512